• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Insulet cuts ribbon on new global headquarters

May 2, 2019 By Danielle Kirsh

InsuletInsulet (NSDQ:PODD) hosted a ribbon cutting ceremony today to open its new global headquarters and manufacturing facility in Acton, Mass.

The new facility is part of a $200 million investment in Massachusetts and is located on 26 acres of land. The site’s groundbreaking ceremony took place a year and a half ago and the investment has created hundreds of jobs locally and is expecting to drive operating efficiencies and increase productivity for its growing U.S. customer base.

Gov. Charlie Baker attended the event, along with company president and CEO Shacey Petrovic, former CEO Pat Sullivan and executive VP and chief operating officer Chuck Alpuche. Massachusetts State Sen. Jamie Eldridge, president and CEO of Massachusetts Life Sciences Center Travis McCready were also in attendance.

At the ribbon-cutting ceremony, Petrovic described the new facility as a “true operational center of excellence.”

“We had to think big to support our rapid growth,” Alpuche said during the event. “It was bold, it was cutting edge and thinking back on it, maybe it was a little crazy. But we have done it.”

“As a global hub for innovation and research, Massachusetts is well-positioned to expand its advanced manufacturing footprint,” Gov. Charlie Baker said in prepared remarks. “Our Administration has prioritized efforts to create an environment that supports the growth of companies like Insulet, and we are glad to see them open this new facility and create jobs here in the Commonwealth.”

The opening of the new facility comes in the midst of Insulet launching its new Omnipod Dash system that wirelessly connects the company’s Personal Diabetes Manager with its tubeless, waterproof insulin pump.

Filed Under: Business/Financial News, Diabetes Tagged With: Insulet

IN CASE YOU MISSED IT

  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS